DrugPatentWatch Database Preview
Hisamitsu Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for HISAMITSU, and what generic alternatives to HISAMITSU drugs are available?
HISAMITSU has two approved drugs.
There are five US patents protecting HISAMITSU drugs.
There are fifty-four patent family members on HISAMITSU drugs in eighteen countries and three supplementary protection certificates in three countries.
Summary for Hisamitsu
| International Patents: | 54 |
| US Patents: | 5 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
| Patent Litigation for Hisamitsu: | See patent lawsuits for Hisamitsu |
Drugs and US Patents for Hisamitsu
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hisamitsu | SECUADO | asenapine | SYSTEM;TRANSDERMAL | 212268-001 | Oct 11, 2019 | RX | Yes | No | 9,687,474 | Start Trial | Y | Start Trial | |||
| Hisamitsu | SECUADO | asenapine | SYSTEM;TRANSDERMAL | 212268-002 | Oct 11, 2019 | RX | Yes | No | 10,583,121 | Start Trial | Y | Start Trial | |||
| Hisamitsu Pharm Co | SALONPAS | menthol; methyl salicylate | PATCH;TOPICAL | 022029-002 | Nov 5, 2012 | OTC | Yes | No | 8,809,615 | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Hisamitsu Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Poland | 2878300 | Start Trial |
| Portugal | 2878299 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2014017593 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Hisamitsu Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0746317 | 10C0056 | France | Start Trial | PRODUCT NAME: ASENAPINE; REGISTRATION NO/DATE: EU/1/10/640/001 20100901 |
| 0746317 | C300461 | Netherlands | Start Trial | PRODUCT NAME: ASENAPINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER HET MALEAAT; REGISTRATION NO/DATE: EU/1/10/640/001-006 20100901 |
| 0746317 | SPC/GB10/046 | United Kingdom | Start Trial | PRODUCT NAME: ASENAPINE; REGISTERED: UK EU/1/10/640/001 20100901; UK EU/1/10/640/002 20100901; UK EU/1/10/640/003 20100901; UK EU/1/10/640/004 20100901; UK EU/1/10/640/005 20100901; UK EU/1/10/640/006 20100901 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
